BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31773297)

  • 1. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G
    Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    Li Z; Li Y; Lu Q; Chen J
    ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    Wang F; Wu LM; Hua XL; Zhao ZZ; Chen XX; Xu JR
    J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Wang H; Xu X; Zhang X; Liu Y; Ouyang L; Du P; Li S; Tian Q; Ling J; Guo Y; Lu H
    Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    Xu X; Zhang X; Tian Q; Wang H; Cui LB; Li S; Tang X; Li B; Dolz J; Ayed IB; Liang Z; Yuan J; Du P; Lu H; Liu Y
    J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F; Chen HG; Zhang RY; Jin D; Xu SS; Wu GY; Xu JR
    Eur Radiol; 2019 Aug; 29(8):4447-4455. PubMed ID: 30666451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
    Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
    Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Zhao SM; Yang TJ; Xu CM; Guo XF; Ma YK; Chen XJ; Li X; He CH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):701-704. PubMed ID: 32773805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.
    Zheng Z; Xu F; Gu Z; Yan Y; Xu T; Liu S; Yao X
    Front Oncol; 2021; 11():619893. PubMed ID: 34055600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
    Zhang S; Song M; Zhao Y; Xu S; Sun Q; Zhai G; Liang D; Wu G; Li ZC
    Eur J Radiol; 2020 Oct; 131():109219. PubMed ID: 32905953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
    Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of radiomics models based on MRI diffusion weighted imaging and apparent diffusion coefficient in differentiating benign and malignant thyroid nodules].
    Xu HJ; Yang Q; He P; Luo HH; Deng WM; Liu Z; Luo DH
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3279-3286. PubMed ID: 37926572
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    Suer E; Hamidi N; Gokce MI; Gulpinar O; Turkolmez K; Beduk Y; Baltaci S
    World J Urol; 2016 Jun; 34(6):847-51. PubMed ID: 26462931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer.
    Wang W; Li W; Wang K; Wu J; Qiu J; Zhang Y; Zhang X; Wang H; Wang X
    Urol Oncol; 2023 Jun; 41(6):294.e1-294.e8. PubMed ID: 36526525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.